Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Immupeutics Medicine Technology Limited

Clinical trials sponsored by Beijing Immupeutics Medicine Technology Limited, explained in plain language.

Not yet recruiting 1

New cancer injection tested in patients out of options

Disease control Not yet recruiting

This is the first human study of an experimental injection called IPM514 for people with advanced esophageal cancer that has spread or returned after standard treatments. The main goal is to find a safe dose by testing six different strength levels in 36 patients. Researchers wil…

Phase: PHASE1 • Sponsor: Beijing Immupeutics Medicine Technology Limited • Aim: Disease control

Last updated Mar 06, 2026 15:38 UTC